Diversified Healthcare Trust (DHCNL) — Financial statements
Income statement, balance sheet, and cash flow for Diversified Healthcare Trust — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,538↑2.8% | 1,495↑6.0% | 1,410↑9.9% | 1,284↓7.2% | 1,383 | |
| Cost of Revenue | 1,783↑43.9% | 1,239↑4.6% | 1,185↑6.8% | 1,109↑1.6% | 1,092 | |
| Gross Profit | -245↓195.7% | 256↑13.8% | 225↑29.1% | 174↓40.1% | 291 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 46↑71.6% | 27↑1.5% | 26↓1.1% | 26↓22.4% | 34 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 46↑71.6% | 27↑1.5% | 26↓1.1% | 26↓22.4% | 34 | |
| Other Expenses | -252 | 0.00 | 0.00↓100.0% | 239↓11.7% | 271 | |
| Operating Expenses | -206↓877.1% | 27↑1.5% | 26↓90.2% | 266↓12.9% | 305 | |
| Total Costs & Expenses | 1,577↑24.6% | 1,266↑4.5% | 1,211↓11.9% | 1,375↓1.6% | 1,397 | |
| Operating Results | ||||||
| Operating Income | -39↓117.1% | 230↑15.4% | 199↑318.3% | -91↓560.1% | -14 | |
| Depreciation & Amortization | 262↓8.1% | 285↑0.4% | 284↑18.5% | 240↓11.7% | 271 | |
| EBITDA | 182↓20.7% | 230↑15.6% | 199↓53.5% | 428↓39.6% | 708 | |
| EBIT | -80↓44.5% | -55↑35.1% | -85↓145.1% | 188↓56.9% | 437 | |
| Interest & Other Income | ||||||
| Net Interest Income | -204↑9.6% | -226↓28.4% | -176↑8.9% | -193↑17.7% | -235 | |
| Interest Income | 0.00↓100.0% | 9↓42.4% | 16↓2.5% | 16↓22.8% | 21 | |
| Interest Expense | 204↓13.1% | 235↑22.7% | 192↓8.4% | 209↓18.1% | 256 | |
| Non-Operating Income | 40↓85.8% | 285↑0.3% | 284↑201.6% | -279↑38.0% | -451 | |
| Other Income / Expenses | -245↑59.2% | -600↓21.8% | -492↓746.4% | 76↓61.0% | 195 | |
| Income Before Tax | -284↑23.2% | -370↓26.2% | -293↓1845.9% | -15↓108.3% | 181 | |
| Income Tax Expense | 2↑273.2% | 0.47↑4.9% | 0.45↓37.3% | 0.71↓50.3% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -286↑22.8% | -370↓26.1% | -294↓1761.1% | -16↓108.8% | 180 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -286↑22.8% | -370↓26.1% | -294↓1761.1% | -16↓109.0% | 175 | |
| Bottom-Line Net Income | -286↑22.8% | -370↓26.1% | -294↓1761.1% | -16↓109.0% | 175 | |
| EPS (Basic) | -1.19↑23.2% | -1.55↓26.0% | -1.23↓1758.0% | -0.07↓109.1% | 0.73 | |
| EPS (Diluted) | -1.19↑23.2% | -1.55↓26.0% | -1.23↓1758.0% | -0.07↓109.1% | 0.73 | |
| Weighted Average Shares | 240↑0.3% | 240↑0.3% | 239↑0.2% | 238↑0.1% | 238 | |
| Weighted Average Diluted Shares | 240↑0.3% | 240↑0.3% | 239↑0.2% | 238↑0.1% | 238 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.